Products

The compound 4-(2,3-Dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-(2-cyano-ethyl) ester 5-methyl ester refers to a chemical often used in pharmaceutical research and development. Let's break down its structure and potential uses.The compound belongs to a class of compounds known as dihydropyridines (DHPs). DHPs are widely studied for their potential application as calcium channel blockers (CCBs) due to their ability to block L-type calcium channels. This particular compound is a modified derivative of a dihydropyridine, with the addition of ester functional groups.Calcium channel blockers are commonly used in the treatment of various cardiovascular conditions, most notably hypertension (high blood pressure). They work by inhibiting the entry of calcium ions into smooth muscle cells lining blood vessels, resulting in relaxation and dilation of the blood vessels. By reducing peripheral vascular resistance, CCBs help lower blood pressure.The structure of the compound suggests that it possesses the potential to act as a calcium channel blocker. However, it is important to note that the compound you mentioned is not a known approved medication. It is likely a research compound used by scientists and pharmaceutical companies to investigate the potential therapeutic properties of DHPs.In laboratory studies, researchers may explore the compound's inhibitory effects on calcium channels, assess its pharmacokinetic profile and metabolic stability, and evaluate its potential therapeutic efficacy in animal models of hypertension or other cardiovascular diseases.Furthermore, the compound's ester groups indicate that it may have improved solubility or metabolic properties compared to other dihydropyridines. Modifications to the ester functional groups can influence factors such as bioavailability, half-life, or cell membrane permeability.In summary, the compound 4-(2,3-Dichloro-phenyl)-2,6-dimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-(2-cyano-ethyl) ester 5-methyl ester is a dihydropyridine derivative that likely possesses potential as a calcium channel blocker. As an experimental compound, its use would primarily extend to research purposes, where it could be investigated for its calcium channel-blocking properties and potential applications in the treatment of various cardiovascular conditions.